ROYALTY AGREEMENTRoyalty Agreement • May 21st, 2015 • Immune Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMay 21st, 2015 Company IndustryTHIS ROYALTY AGREEMENT (this “Agreement”) is entered into and effective as of May 15, 2015, by and between Immune Therapeutics, Inc., a Florida corporation formerly known as TNI BioTech, Inc. (the “Company”), and Chris Pearce, individually (“Pearce”).